Systemic racism is a public health crisis. The U.S. Food and Drug Administration applies the Population Health Standard in tobacco product review processes by weighing anticipated health benefits against risks associated with a given commercial tobacco product at the population level. However, systemic racism (ie, discriminatory policies and practices) contributes to an inequitable distribution of tobacco-related health benefits and risks between white and Black/African Americans at the population level. This Editorial describe how systemic racism contributes to disparities in tobacco-related outcomes and why these disparities are relevant for population-level risk assessments, then discusses four possible options for Black-centered data standards relevant to tobacco product review processes.
Send this to a friend